Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02019121 · ClinicalTrials.gov registry record
Dexmedetomidine and Renal Transplants
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 797
- Enrollment target
NCT02019121: Completed study, sponsored by University of California, Davis.
NCT02019121 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 797 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02019121 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 797 participants
- Enrollment target
Study Summary
Investigators aim to retrospectively research patients undergoing renal transplants that received dexmedetomidine perioperatively to see if dexmedetomidine use protects renal function. Investigators hope to elucidate any association between renal transplant patients and perioperative dexmedetomidine administration, these include (but are not limited to) UOP, Cr/GFR, morbidity, mortality, in hospital complications and failure rate. Investigators will research both living and cadaveric renal transplants.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 797 participants |
| Start Date | 2013-10 |
| Est. Completion | 2020-02 |
What the finished NCT02019121 record still lists
NCT02019121 is an observational study that tracks outcomes without assigning an intervention. The registered 797 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02019121 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02019121 about?
NCT02019121 is a clinical study titled "Dexmedetomidine and Renal Transplants". Investigators aim to retrospectively research patients undergoing renal transplants that received dexmedetomidine perioperatively to see if dexmedetomidine use protects renal function. Investigators hope to elucidate any association between renal transplant patients and perioperative dexmedetomidine...
What is the current status of trial NCT02019121?
This trial is currently completed. The enrollment target is 797 participants. The study started on 2013-10. Estimated completion is 2020-02.
Who is sponsoring clinical trial NCT02019121?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06051058 · 798 participants · NA
Care Transitions App for Patients With Multiple Chronic Conditions
- NCT05150691 · 796 participants · Phase 1
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
- NCT06208150 · 795 participants · Phase 3
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
- NCT06724172 · 795 participants · NA
CHIME: Comparing Health Interventions for Maternal Equity
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia